img

Global Over-The-Counter (OTC) Drugs Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Over-The-Counter (OTC) Drugs Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Over-The-Counter (OTC) Drugs report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Over-The-Counter (OTC) Drugs market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital Pharmacy and Retail Pharmacy are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Over-The-Counter (OTC) Drugs industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Over-The-Counter (OTC) Drugs key manufacturers include Bayer, Boehringer Ingelheim, GSK, Novartis, Pfizer, PGT healthcare, Sanofi, Teva Pharmaceuticals and Takeda, etc. Bayer, Boehringer Ingelheim, GSK are top 3 players and held % sales share in total in 2022.
Over-The-Counter (OTC) Drugs can be divided into Cold and Flu Products, Analgesics, Dermatological Products and Gastrointestinal Products, etc. Cold and Flu Products is the mainstream product in the market, accounting for % sales share globally in 2022.
Over-The-Counter (OTC) Drugs is widely used in various fields, such as Hospital Pharmacy, Retail Pharmacy and Online Pharmacy,, etc. Hospital Pharmacy provides greatest supports to the Over-The-Counter (OTC) Drugs industry development. In 2022, global % sales of Over-The-Counter (OTC) Drugs went into Hospital Pharmacy filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Over-The-Counter (OTC) Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Sale Channel and Regions Listed in the Report



By Company


Bayer
Boehringer Ingelheim
GSK
Novartis
Pfizer
PGT healthcare
Sanofi
Teva Pharmaceuticals
Takeda
Cipla
Sun Pharmaceutical Industries
Glenmark
Innovus Pharmaceuticals
Segment by Type
Cold and Flu Products
Analgesics
Dermatological Products
Gastrointestinal Products
Vitamin
Other
Segment by Sale Channel
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Over-The-Counter (OTC) Drugs market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Over-The-Counter (OTC) Drugs, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Over-The-Counter (OTC) Drugs industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Over-The-Counter (OTC) Drugs in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Sale Channel, Volume and Revenue analysis of Each Sale Channel in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Over-The-Counter (OTC) Drugs introduction, etc. Over-The-Counter (OTC) Drugs Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Over-The-Counter (OTC) Drugs market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Over-The-Counter (OTC) Drugs Market Overview
1.1 Over-The-Counter (OTC) Drugs Product Overview
1.2 Over-The-Counter (OTC) Drugs Market Segment by Type
1.2.1 Cold and Flu Products
1.2.2 Analgesics
1.2.3 Dermatological Products
1.2.4 Gastrointestinal Products
1.2.5 Vitamin
1.2.6 Other
1.3 Global Over-The-Counter (OTC) Drugs Market Size by Type
1.3.1 Global Over-The-Counter (OTC) Drugs Market Size Overview by Type (2018-2034)
1.3.2 Global Over-The-Counter (OTC) Drugs Historic Market Size Review by Type (2018-2024)
1.3.3 Global Over-The-Counter (OTC) Drugs Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Over-The-Counter (OTC) Drugs Sales Breakdown by Type (2018-2024)
1.4.2 Europe Over-The-Counter (OTC) Drugs Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Over-The-Counter (OTC) Drugs Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Over-The-Counter (OTC) Drugs Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Over-The-Counter (OTC) Drugs Sales Breakdown by Type (2018-2024)
2 Global Over-The-Counter (OTC) Drugs Market Competition by Company
2.1 Global Top Players by Over-The-Counter (OTC) Drugs Sales (2018-2024)
2.2 Global Top Players by Over-The-Counter (OTC) Drugs Revenue (2018-2024)
2.3 Global Top Players by Over-The-Counter (OTC) Drugs Price (2018-2024)
2.4 Global Top Manufacturers Over-The-Counter (OTC) Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Over-The-Counter (OTC) Drugs Market Competitive Situation and Trends
2.5.1 Over-The-Counter (OTC) Drugs Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Over-The-Counter (OTC) Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Over-The-Counter (OTC) Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Over-The-Counter (OTC) Drugs Market
2.8 Key Manufacturers Over-The-Counter (OTC) Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Over-The-Counter (OTC) Drugs Status and Outlook by Region
3.1 Global Over-The-Counter (OTC) Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Over-The-Counter (OTC) Drugs Historic Market Size by Region
3.2.1 Global Over-The-Counter (OTC) Drugs Sales in Volume by Region (2018-2024)
3.2.2 Global Over-The-Counter (OTC) Drugs Sales in Value by Region (2018-2024)
3.2.3 Global Over-The-Counter (OTC) Drugs Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Over-The-Counter (OTC) Drugs Forecasted Market Size by Region
3.3.1 Global Over-The-Counter (OTC) Drugs Sales in Volume by Region (2024-2034)
3.3.2 Global Over-The-Counter (OTC) Drugs Sales in Value by Region (2024-2034)
3.3.3 Global Over-The-Counter (OTC) Drugs Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Over-The-Counter (OTC) Drugs by Sale Channel
4.1 Over-The-Counter (OTC) Drugs Market Segment by Sale Channel
4.1.1 Hospital Pharmacy
4.1.2 Retail Pharmacy
4.1.3 Online Pharmacy
4.2 Global Over-The-Counter (OTC) Drugs Market Size by Sale Channel
4.2.1 Global Over-The-Counter (OTC) Drugs Market Size Overview by Sale Channel (2018-2034)
4.2.2 Global Over-The-Counter (OTC) Drugs Historic Market Size Review by Sale Channel (2018-2024)
4.2.3 Global Over-The-Counter (OTC) Drugs Forecasted Market Size by Sale Channel (2024-2034)
4.3 Key Regions Market Size Segment by Sale Channel
4.3.1 North America Over-The-Counter (OTC) Drugs Sales Breakdown by Sale Channel (2018-2024)
4.3.2 Europe Over-The-Counter (OTC) Drugs Sales Breakdown by Sale Channel (2018-2024)
4.3.3 Asia-Pacific Over-The-Counter (OTC) Drugs Sales Breakdown by Sale Channel (2018-2024)
4.3.4 Latin America Over-The-Counter (OTC) Drugs Sales Breakdown by Sale Channel (2018-2024)
4.3.5 Middle East and Africa Over-The-Counter (OTC) Drugs Sales Breakdown by Sale Channel (2018-2024)
5 North America Over-The-Counter (OTC) Drugs by Country
5.1 North America Over-The-Counter (OTC) Drugs Historic Market Size by Country
5.1.1 North America Over-The-Counter (OTC) Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Over-The-Counter (OTC) Drugs Sales in Volume by Country (2018-2024)
5.1.3 North America Over-The-Counter (OTC) Drugs Sales in Value by Country (2018-2024)
5.2 North America Over-The-Counter (OTC) Drugs Forecasted Market Size by Country
5.2.1 North America Over-The-Counter (OTC) Drugs Sales in Volume by Country (2024-2034)
5.2.2 North America Over-The-Counter (OTC) Drugs Sales in Value by Country (2024-2034)
6 Europe Over-The-Counter (OTC) Drugs by Country
6.1 Europe Over-The-Counter (OTC) Drugs Historic Market Size by Country
6.1.1 Europe Over-The-Counter (OTC) Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Over-The-Counter (OTC) Drugs Sales in Volume by Country (2018-2024)
6.1.3 Europe Over-The-Counter (OTC) Drugs Sales in Value by Country (2018-2024)
6.2 Europe Over-The-Counter (OTC) Drugs Forecasted Market Size by Country
6.2.1 Europe Over-The-Counter (OTC) Drugs Sales in Volume by Country (2024-2034)
6.2.2 Europe Over-The-Counter (OTC) Drugs Sales in Value by Country (2024-2034)
7 Asia-Pacific Over-The-Counter (OTC) Drugs by Region
7.1 Asia-Pacific Over-The-Counter (OTC) Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Over-The-Counter (OTC) Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Over-The-Counter (OTC) Drugs Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Over-The-Counter (OTC) Drugs Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Over-The-Counter (OTC) Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Over-The-Counter (OTC) Drugs Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Over-The-Counter (OTC) Drugs Sales in Value by Region (2024-2034)
8 Latin America Over-The-Counter (OTC) Drugs by Country
8.1 Latin America Over-The-Counter (OTC) Drugs Historic Market Size by Country
8.1.1 Latin America Over-The-Counter (OTC) Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Over-The-Counter (OTC) Drugs Sales in Volume by Country (2018-2024)
8.1.3 Latin America Over-The-Counter (OTC) Drugs Sales in Value by Country (2018-2024)
8.2 Latin America Over-The-Counter (OTC) Drugs Forecasted Market Size by Country
8.2.1 Latin America Over-The-Counter (OTC) Drugs Sales in Volume by Country (2024-2034)
8.2.2 Latin America Over-The-Counter (OTC) Drugs Sales in Value by Country (2024-2034)
9 Middle East and Africa Over-The-Counter (OTC) Drugs by Country
9.1 Middle East and Africa Over-The-Counter (OTC) Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Over-The-Counter (OTC) Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Over-The-Counter (OTC) Drugs Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Over-The-Counter (OTC) Drugs Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Over-The-Counter (OTC) Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Over-The-Counter (OTC) Drugs Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Over-The-Counter (OTC) Drugs Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Bayer
10.1.1 Bayer Company Information
10.1.2 Bayer Introduction and Business Overview
10.1.3 Bayer Over-The-Counter (OTC) Drugs Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Bayer Over-The-Counter (OTC) Drugs Products Offered
10.1.5 Bayer Recent Development
10.2 Boehringer Ingelheim
10.2.1 Boehringer Ingelheim Company Information
10.2.2 Boehringer Ingelheim Introduction and Business Overview
10.2.3 Boehringer Ingelheim Over-The-Counter (OTC) Drugs Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Boehringer Ingelheim Over-The-Counter (OTC) Drugs Products Offered
10.2.5 Boehringer Ingelheim Recent Development
10.3 GSK
10.3.1 GSK Company Information
10.3.2 GSK Introduction and Business Overview
10.3.3 GSK Over-The-Counter (OTC) Drugs Sales, Revenue and Gross Margin (2018-2024)
10.3.4 GSK Over-The-Counter (OTC) Drugs Products Offered
10.3.5 GSK Recent Development
10.4 Novartis
10.4.1 Novartis Company Information
10.4.2 Novartis Introduction and Business Overview
10.4.3 Novartis Over-The-Counter (OTC) Drugs Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Novartis Over-The-Counter (OTC) Drugs Products Offered
10.4.5 Novartis Recent Development
10.5 Pfizer
10.5.1 Pfizer Company Information
10.5.2 Pfizer Introduction and Business Overview
10.5.3 Pfizer Over-The-Counter (OTC) Drugs Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Pfizer Over-The-Counter (OTC) Drugs Products Offered
10.5.5 Pfizer Recent Development
10.6 PGT healthcare
10.6.1 PGT healthcare Company Information
10.6.2 PGT healthcare Introduction and Business Overview
10.6.3 PGT healthcare Over-The-Counter (OTC) Drugs Sales, Revenue and Gross Margin (2018-2024)
10.6.4 PGT healthcare Over-The-Counter (OTC) Drugs Products Offered
10.6.5 PGT healthcare Recent Development
10.7 Sanofi
10.7.1 Sanofi Company Information
10.7.2 Sanofi Introduction and Business Overview
10.7.3 Sanofi Over-The-Counter (OTC) Drugs Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Sanofi Over-The-Counter (OTC) Drugs Products Offered
10.7.5 Sanofi Recent Development
10.8 Teva Pharmaceuticals
10.8.1 Teva Pharmaceuticals Company Information
10.8.2 Teva Pharmaceuticals Introduction and Business Overview
10.8.3 Teva Pharmaceuticals Over-The-Counter (OTC) Drugs Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Teva Pharmaceuticals Over-The-Counter (OTC) Drugs Products Offered
10.8.5 Teva Pharmaceuticals Recent Development
10.9 Takeda
10.9.1 Takeda Company Information
10.9.2 Takeda Introduction and Business Overview
10.9.3 Takeda Over-The-Counter (OTC) Drugs Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Takeda Over-The-Counter (OTC) Drugs Products Offered
10.9.5 Takeda Recent Development
10.10 Cipla
10.10.1 Cipla Company Information
10.10.2 Cipla Introduction and Business Overview
10.10.3 Cipla Over-The-Counter (OTC) Drugs Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Cipla Over-The-Counter (OTC) Drugs Products Offered
10.10.5 Cipla Recent Development
10.11 Sun Pharmaceutical Industries
10.11.1 Sun Pharmaceutical Industries Company Information
10.11.2 Sun Pharmaceutical Industries Introduction and Business Overview
10.11.3 Sun Pharmaceutical Industries Over-The-Counter (OTC) Drugs Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Sun Pharmaceutical Industries Over-The-Counter (OTC) Drugs Products Offered
10.11.5 Sun Pharmaceutical Industries Recent Development
10.12 Glenmark
10.12.1 Glenmark Company Information
10.12.2 Glenmark Introduction and Business Overview
10.12.3 Glenmark Over-The-Counter (OTC) Drugs Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Glenmark Over-The-Counter (OTC) Drugs Products Offered
10.12.5 Glenmark Recent Development
10.13 Innovus Pharmaceuticals
10.13.1 Innovus Pharmaceuticals Company Information
10.13.2 Innovus Pharmaceuticals Introduction and Business Overview
10.13.3 Innovus Pharmaceuticals Over-The-Counter (OTC) Drugs Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Innovus Pharmaceuticals Over-The-Counter (OTC) Drugs Products Offered
10.13.5 Innovus Pharmaceuticals Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Over-The-Counter (OTC) Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Over-The-Counter (OTC) Drugs Industrial Chain Analysis
11.4 Over-The-Counter (OTC) Drugs Market Dynamics
11.4.1 Over-The-Counter (OTC) Drugs Industry Trends
11.4.2 Over-The-Counter (OTC) Drugs Market Drivers
11.4.3 Over-The-Counter (OTC) Drugs Market Challenges
11.4.4 Over-The-Counter (OTC) Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Over-The-Counter (OTC) Drugs Distributors
12.3 Over-The-Counter (OTC) Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Cold and Flu Products
Table 2. Major Company of Analgesics
Table 3. Major Company of Dermatological Products
Table 4. Major Company of Gastrointestinal Products
Table 5. Major Company of Vitamin
Table 6. Major Company of Other
Table 7. Global Over-The-Counter (OTC) Drugs Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 8. Global Over-The-Counter (OTC) Drugs Sales by Type (2018-2024) & (K Units)
Table 9. Global Over-The-Counter (OTC) Drugs Sales Market Share in Volume by Type (2018-2024)
Table 10. Global Over-The-Counter (OTC) Drugs Sales by Type (2018-2024) & (US& Million)
Table 11. Global Over-The-Counter (OTC) Drugs Market Share in Value by Type (2018-2024)
Table 12. Global Over-The-Counter (OTC) Drugs Price by Type (2018-2024) & (USD/Unit)
Table 13. Global Over-The-Counter (OTC) Drugs Sales by Type (2024-2034) & (K Units)
Table 14. Global Over-The-Counter (OTC) Drugs Sales Market Share in Volume by Type (2024-2034)
Table 15. Global Over-The-Counter (OTC) Drugs Sales by Type (2024-2034) & (US$ Million)
Table 16. Global Over-The-Counter (OTC) Drugs Sales Market Share in Value by Type (2024-2034)
Table 17. Global Over-The-Counter (OTC) Drugs Price by Type (2024-2034) & (USD/Unit)
Table 18. North America Over-The-Counter (OTC) Drugs Sales by Type (2018-2024) & (K Units)
Table 19. North America Over-The-Counter (OTC) Drugs Sales by Type (2018-2024) & (US$ Million)
Table 20. Europe Over-The-Counter (OTC) Drugs Sales (K Units) by Type (2018-2024)
Table 21. Europe Over-The-Counter (OTC) Drugs Sales by Type (2018-2024) & (US$ Million)
Table 22. Asia-Pacific Over-The-Counter (OTC) Drugs Sales (K Units) by Type (2018-2024)
Table 23. Asia-Pacific Over-The-Counter (OTC) Drugs Sales by Type (2018-2024) & (US$ Million)
Table 24. Latin America Over-The-Counter (OTC) Drugs Sales (K Units) by Type (2018-2024)
Table 25. Latin America Over-The-Counter (OTC) Drugs Sales by Type (2018-2024) & (US$ Million)
Table 26. Middle East and Africa Over-The-Counter (OTC) Drugs Sales (K Units) by Type (2018-2024)
Table 27. Middle East and Africa Over-The-Counter (OTC) Drugs Sales by Type (2018-2024) & (US$ Million)
Table 28. Global Over-The-Counter (OTC) Drugs Sales by Company (2018-2024) & (K Units)
Table 29. Global Over-The-Counter (OTC) Drugs Sales Share by Company (2018-2024)
Table 30. Global Over-The-Counter (OTC) Drugs Revenue by Company (2018-2024) & (US$ Million)
Table 31. Global Over-The-Counter (OTC) Drugs Revenue Share by Company (2018-2024)
Table 32. Global Market Over-The-Counter (OTC) Drugs Price by Company (2018-2024) & (USD/Unit)
Table 33. Global Over-The-Counter (OTC) Drugs Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 34. Global Over-The-Counter (OTC) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 35. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Over-The-Counter (OTC) Drugs as of 2022)
Table 36. Date of Key Manufacturers Enter into Over-The-Counter (OTC) Drugs Market
Table 37. Key Manufacturers Over-The-Counter (OTC) Drugs Product Type
Table 38. Mergers & Acquisitions, Expansion Plans
Table 39. Global Over-The-Counter (OTC) Drugs Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 40. Global Over-The-Counter (OTC) Drugs Sales by Region (2018-2024) & (K Units)
Table 41. Global Over-The-Counter (OTC) Drugs Sales Market Share in Volume by Region (2018-2024)
Table 42. Global Over-The-Counter (OTC) Drugs Sales by Region (2018-2024) & (US$ Million)
Table 43. Global Over-The-Counter (OTC) Drugs Sales Market Share in Value by Region (2018-2024)
Table 44. Global Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 45. Global Over-The-Counter (OTC) Drugs Sales by Region (2024-2034) & (K Units)
Table 46. Global Over-The-Counter (OTC) Drugs Sales Market Share in Volume by Region (2024-2034)
Table 47. Global Over-The-Counter (OTC) Drugs Sales by Region (2024-2034) & (US$ Million)
Table 48. Global Over-The-Counter (OTC) Drugs Sales Market Share in Value by Region (2024-2034)
Table 49. Global Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 50. Global Over-The-Counter (OTC) Drugs Sales by Sale Channel: 2018 VS 2022 VS 2034 (US$ Million)
Table 51. Global Over-The-Counter (OTC) Drugs Sales by Sale Channel (2018-2024) & (K Units)
Table 52. Global Over-The-Counter (OTC) Drugs Sales Market Share in Volume by Sale Channel (2018-2024)
Table 53. Global Over-The-Counter (OTC) Drugs Sales by Sale Channel (2018-2024) & (US$ Million)
Table 54. Global Over-The-Counter (OTC) Drugs Sales Market Share in Value by Sale Channel (2018-2024)
Table 55. Global Over-The-Counter (OTC) Drugs Price by Sale Channel (2018-2024) & (USD/Unit)
Table 56. Global Over-The-Counter (OTC) Drugs Sales by Sale Channel (2024-2034) & (K Units)
Table 57. Global Over-The-Counter (OTC) Drugs Sales Market Share in Volume by Sale Channel (2024-2034)
Table 58. Global Over-The-Counter (OTC) Drugs Sales by Sale Channel (2024-2034) & (US$ Million)
Table 59. Global Over-The-Counter (OTC) Drugs Sales Market Share in Value by Sale Channel (2024-2034)
Table 60. Global Over-The-Counter (OTC) Drugs Price by Sale Channel (2024-2034) & (USD/Unit)
Table 61. North America Over-The-Counter (OTC) Drugs Sales by Sale Channel (2018-2024) (K Units)
Table 62. North America Over-The-Counter (OTC) Drugs Sales by Sale Channel (2018-2024) & (US$ Million)
Table 63. Europe Over-The-Counter (OTC) Drugs Sales by Sale Channel (2018-2024) (K Units)
Table 64. Europe Over-The-Counter (OTC) Drugs Sales by Sale Channel (2018-2024) & (US$ Million)
Table 65. Asia-Pacific Over-The-Counter (OTC) Drugs Sales by Sale Channel (2018-2024) (K Units)
Table 66. Asia-Pacific Over-The-Counter (OTC) Drugs Sales by Sale Channel (2018-2024) & (US$ Million)
Table 67. Latin America Over-The-Counter (OTC) Drugs Sales by Sale Channel (2018-2024) (K Units)
Table 68. Latin America Over-The-Counter (OTC) Drugs Sales by Sale Channel (2018-2024) & (US$ Million)
Table 69. Middle East and Africa Over-The-Counter (OTC) Drugs Sales by Sale Channel (2018-2024) (K Units)
Table 70. Middle East and Africa Over-The-Counter (OTC) Drugs Sales by Sale Channel (2018-2024) & (US$ Million)
Table 71. North America Over-The-Counter (OTC) Drugs Sales by Country (2018-2024) & (K Units)
Table 72. North America Over-The-Counter (OTC) Drugs Sales Market Share in Volume by Country (2018-2024)
Table 73. North America Over-The-Counter (OTC) Drugs Sales by Country (2018-2024) & (US$ Million)
Table 74. North America Over-The-Counter (OTC) Drugs Sales Market Share in Value by Country (2018-2024)
Table 75. North America Over-The-Counter (OTC) Drugs Sales by Country (2024-2034) & (K Units)
Table 76. North America Over-The-Counter (OTC) Drugs Sales Market Share in Volume by Country (2024-2034)
Table 77. North America Over-The-Counter (OTC) Drugs Sales by Country (2024-2034) & (US$ Million)
Table 78. North America Over-The-Counter (OTC) Drugs Sales Market Share in Value by Country (2024-2034)
Table 79. Europe Over-The-Counter (OTC) Drugs Sales by Country (2018-2024) & (K Units)
Table 80. Europe Over-The-Counter (OTC) Drugs Sales Market Share in Volume by Country (2018-2024)
Table 81. Europe Over-The-Counter (OTC) Drugs Sales by Country (2018-2024) & (US$ Million)
Table 82. Europe Over-The-Counter (OTC) Drugs Sales Market Share in Value by Country (2018-2024)
Table 83. Europe Over-The-Counter (OTC) Drugs Sales by Country (2024-2034) & (K Units)
Table 84. Europe Over-The-Counter (OTC) Drugs Sales Market Share in Volume by Country (2024-2034)
Table 85. Europe Over-The-Counter (OTC) Drugs Sales by Country (2024-2034) & (US$ Million)
Table 86. Europe Over-The-Counter (OTC) Drugs Sales Market Share in Value by Country (2024-2034)
Table 87. Asia-Pacific Over-The-Counter (OTC) Drugs Sales by Region (2018-2024) & (K Units)
Table 88. Asia-Pacific Over-The-Counter (OTC) Drugs Sales Market Share in Volume by Region (2018-2024)
Table 89. Asia-Pacific Over-The-Counter (OTC) Drugs Sales by Region (2018-2024) & (US$ Million)
Table 90. Asia-Pacific Over-The-Counter (OTC) Drugs Sales Market Share in Value by Region (2018-2024)
Table 91. Asia-Pacific Over-The-Counter (OTC) Drugs Sales by Region (2024-2034) & (K Units)
Table 92. Asia-Pacific Over-The-Counter (OTC) Drugs Sales Market Share in Volume by Region (2024-2034)
Table 93. Asia-Pacific Over-The-Counter (OTC) Drugs Sales by Region (2024-2034) & (US$ Million)
Table 94. Asia-Pacific Over-The-Counter (OTC) Drugs Sales Market Share in Value by Region (2024-2034)
Table 95. Latin America Over-The-Counter (OTC) Drugs Sales by Country (2018-2024) & (K Units)
Table 96. Latin America Over-The-Counter (OTC) Drugs Sales Market Share in Volume by Country (2018-2024)
Table 97. Latin America Over-The-Counter (OTC) Drugs Sales by Country (2018-2024) & (US$ Million)
Table 98. Latin America Over-The-Counter (OTC) Drugs Sales Market Share in Value by Country (2018-2024)
Table 99. Latin America Over-The-Counter (OTC) Drugs Sales by Country (2024-2034) & (K Units)
Table 100. Latin America Over-The-Counter (OTC) Drugs Sales Market Share in Volume by Country (2024-2034)
Table 101. Latin America Over-The-Counter (OTC) Drugs Sales by Country (2024-2034) & (US$ Million)
Table 102. Latin America Over-The-Counter (OTC) Drugs Sales Market Share in Value by Country (2024-2034)
Table 103. Middle East and Africa Over-The-Counter (OTC) Drugs Sales by Country (2018-2024) & (K Units)
Table 104. Middle East and Africa Over-The-Counter (OTC) Drugs Sales Market Share in Volume by Country (2018-2024)
Table 105. Middle East and Africa Over-The-Counter (OTC) Drugs Sales by Country (2018-2024) & (US$ Million)
Table 106. Middle East and Africa Over-The-Counter (OTC) Drugs Sales Market Share in Value by Country (2018-2024)
Table 107. Middle East and Africa Over-The-Counter (OTC) Drugs Sales by Country (2024-2034) & (K Units)
Table 108. Middle East and Africa Over-The-Counter (OTC) Drugs Sales Market Share in Volume by Country (2024-2034)
Table 109. Middle East and Africa Over-The-Counter (OTC) Drugs Sales by Country (2024-2034) & (US$ Million)
Table 110. Middle East and Africa Over-The-Counter (OTC) Drugs Sales Market Share in Value by Country (2024-2034)
Table 111. Bayer Company Information
Table 112. Bayer Introduction and Business Overview
Table 113. Bayer Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 114. Bayer Over-The-Counter (OTC) Drugs Product
Table 115. Bayer Recent Development
Table 116. Boehringer Ingelheim Company Information
Table 117. Boehringer Ingelheim Introduction and Business Overview
Table 118. Boehringer Ingelheim Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 119. Boehringer Ingelheim Over-The-Counter (OTC) Drugs Product
Table 120. Boehringer Ingelheim Recent Development
Table 121. GSK Company Information
Table 122. GSK Introduction and Business Overview
Table 123. GSK Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 124. GSK Over-The-Counter (OTC) Drugs Product
Table 125. GSK Recent Development
Table 126. Novartis Company Information
Table 127. Novartis Introduction and Business Overview
Table 128. Novartis Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 129. Novartis Over-The-Counter (OTC) Drugs Product
Table 130. Novartis Recent Development
Table 131. Pfizer Company Information
Table 132. Pfizer Introduction and Business Overview
Table 133. Pfizer Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 134. Pfizer Over-The-Counter (OTC) Drugs Product
Table 135. Pfizer Recent Development
Table 136. PGT healthcare Company Information
Table 137. PGT healthcare Introduction and Business Overview
Table 138. PGT healthcare Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 139. PGT healthcare Over-The-Counter (OTC) Drugs Product
Table 140. PGT healthcare Recent Development
Table 141. Sanofi Company Information
Table 142. Sanofi Introduction and Business Overview
Table 143. Sanofi Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 144. Sanofi Over-The-Counter (OTC) Drugs Product
Table 145. Sanofi Recent Development
Table 146. Teva Pharmaceuticals Company Information
Table 147. Teva Pharmaceuticals Introduction and Business Overview
Table 148. Teva Pharmaceuticals Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 149. Teva Pharmaceuticals Over-The-Counter (OTC) Drugs Product
Table 150. Teva Pharmaceuticals Recent Development
Table 151. Takeda Company Information
Table 152. Takeda Introduction and Business Overview
Table 153. Takeda Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 154. Takeda Over-The-Counter (OTC) Drugs Product
Table 155. Takeda Recent Development
Table 156. Cipla Company Information
Table 157. Cipla Introduction and Business Overview
Table 158. Cipla Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 159. Cipla Over-The-Counter (OTC) Drugs Product
Table 160. Cipla Recent Development
Table 161. Sun Pharmaceutical Industries Company Information
Table 162. Sun Pharmaceutical Industries Introduction and Business Overview
Table 163. Sun Pharmaceutical Industries Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 164. Sun Pharmaceutical Industries Over-The-Counter (OTC) Drugs Product
Table 165. Sun Pharmaceutical Industries Recent Development
Table 166. Glenmark Company Information
Table 167. Glenmark Introduction and Business Overview
Table 168. Glenmark Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 169. Glenmark Over-The-Counter (OTC) Drugs Product
Table 170. Glenmark Recent Development
Table 171. Innovus Pharmaceuticals Company Information
Table 172. Innovus Pharmaceuticals Introduction and Business Overview
Table 173. Innovus Pharmaceuticals Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 174. Innovus Pharmaceuticals Over-The-Counter (OTC) Drugs Product
Table 175. Innovus Pharmaceuticals Recent Development
Table 176. Key Raw Materials Lists
Table 177. Raw Materials Key Suppliers Lists
Table 178. Over-The-Counter (OTC) Drugs Market Trends
Table 179. Over-The-Counter (OTC) Drugs Market Drivers
Table 180. Over-The-Counter (OTC) Drugs Market Challenges
Table 181. Over-The-Counter (OTC) Drugs Market Restraints
Table 182. Over-The-Counter (OTC) Drugs Distributors List
Table 183. Over-The-Counter (OTC) Drugs Downstream Customers
Table 184. Research Programs/Design for This Report
Table 185. Key Data Information from Secondary Sources
Table 186. Key Data Information from Primary Sources
List of Figures
Figure 1. Over-The-Counter (OTC) Drugs Product Picture
Figure 2. Global Over-The-Counter (OTC) Drugs Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Over-The-Counter (OTC) Drugs Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Over-The-Counter (OTC) Drugs Sales Status and Outlook (2018-2034) & (K Units)
Figure 5. Product Picture of Cold and Flu Products
Figure 6. Global Cold and Flu Products Sales YoY Growth (2018-2034) & (K Units)
Figure 7. Product Picture of Analgesics
Figure 8. Global Analgesics Sales YoY Growth (2018-2034) & (K Units)
Figure 9. Product Picture of Dermatological Products
Figure 10. Global Dermatological Products Sales YoY Growth (2018-2034) & (K Units)
Figure 11. Product Picture of Gastrointestinal Products
Figure 12. Global Gastrointestinal Products Sales YoY Growth (2018-2034) & (K Units)
Figure 13. Product Picture of Vitamin
Figure 14. Global Vitamin Sales YoY Growth (2018-2034) & (K Units)
Figure 15. Product Picture of Other
Figure 16. Global Other Sales YoY Growth (2018-2034) & (K Units)
Figure 17. Global Over-The-Counter (OTC) Drugs Sales by Type (2018-2034) & (US$ Million)
Figure 18. Global Over-The-Counter (OTC) Drugs Sales Market Share by Type in 2022 & 2034
Figure 19. North America Over-The-Counter (OTC) Drugs Sales Market Share in Volume by Type in 2022
Figure 20. North America Over-The-Counter (OTC) Drugs Sales Market Share in Value by Type in 2022
Figure 21. Europe Over-The-Counter (OTC) Drugs Sales Market Share in Volume by Type in 2022
Figure 22. Europe Over-The-Counter (OTC) Drugs Sales Market Share in Value by Type in 2022
Figure 23. Asia-Pacific Over-The-Counter (OTC) Drugs Sales Market Share in Volume by Type in 2022
Figure 24. Asia-Pacific Over-The-Counter (OTC) Drugs Sales Market Share in Value by Type in 2022
Figure 25. Latin America Over-The-Counter (OTC) Drugs Sales Market Share in Volume by Type in 2022
Figure 26. Latin America Over-The-Counter (OTC) Drugs Sales Market Share in Value by Type in 2022
Figure 27. Middle East and Africa Over-The-Counter (OTC) Drugs Sales Market Share in Volume by Type in 2022
Figure 28. Middle East and Africa Over-The-Counter (OTC) Drugs Sales Market Share in Value by Type in 2022
Figure 29. The 5 and 10 Largest Manufacturers in the World: Market Share by Over-The-Counter (OTC) Drugs Sales in 2022
Figure 30. The 5 and 10 Largest Manufacturers in the World: Market Share by Over-The-Counter (OTC) Drugs Revenue in 2022
Figure 31. Over-The-Counter (OTC) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Product Picture of Hospital Pharmacy
Figure 33. Global Hospital Pharmacy Sales YoY Growth (2018-2034) & (K Units)
Figure 34. Product Picture of Retail Pharmacy
Figure 35. Global Retail Pharmacy Sales YoY Growth (2018-2034) & (K Units)
Figure 36. Product Picture of Online Pharmacy
Figure 37. Global Online Pharmacy Sales YoY Growth (2018-2034) & (K Units)
Figure 38. Global Over-The-Counter (OTC) Drugs Sales by Sale Channel (2018-2034) & (US$ Million)
Figure 39. Global Over-The-Counter (OTC) Drugs Sales Market Share by Sale Channel in 2022 & 2034
Figure 40. North America Over-The-Counter (OTC) Drugs Sales Market Share in Volume by Sale Channel in 2022
Figure 41. North America Over-The-Counter (OTC) Drugs Sales Market Share in Value by Sale Channel in 2022
Figure 42. Europe Over-The-Counter (OTC) Drugs Sales Market Share in Volume by Sale Channel in 2022
Figure 43. Europe Over-The-Counter (OTC) Drugs Sales Market Share in Value by Sale Channel in 2022
Figure 44. Asia-Pacific Over-The-Counter (OTC) Drugs Sales Market Share in Volume by Sale Channel in 2022
Figure 45. Asia-Pacific Over-The-Counter (OTC) Drugs Sales Market Share in Value by Sale Channel in 2022
Figure 46. Latin America Over-The-Counter (OTC) Drugs Sales Market Share in Volume by Sale Channel in 2022
Figure 47. Latin America Over-The-Counter (OTC) Drugs Sales Market Share in Value by Sale Channel in 2022
Figure 48. Middle East and Africa Over-The-Counter (OTC) Drugs Sales Market Share in Value by Sale Channel in 2022
Figure 49. Key Raw Materials Price
Figure 50. Over-The-Counter (OTC) Drugs Manufacturing Cost Structure
Figure 51. Over-The-Counter (OTC) Drugs Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed